Clinical Trial Results

Showing: All studies [change]
Condition: Kidney Disease Location: Indiana 7 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2, PHASE3INTERVENTIONAL Alabaster, Alabama +4 more
RECRUITING
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
PHASE3INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Ferric Citrate and Chronic Kidney Disease in Children
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
RaDIANT Health Systems Intervention
NAINTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
PHASE3INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type